Otros idiomas Immunome, Inc.

Acciones

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 01/07/2024			Varia. Cinco días.	Varia. 1 de enero.
12,2 ^USD	+0,83 %		+2,18 %	+14,02 %

27/06	Immunome, Inc. nombra a Phil Tsai director técnico	CI
31/05	IMMUNOME, INC. : recomendación de compra de Piper Sandler	ZM

Immunome Appoints Phil Tsai as Chief Technical Officer	27/06
Immunome, Inc. Appoints Phil Tsai as Chief Technical Officer	27/06
Immunome, Inc.(NasdaqCM:IMNM) added to S&P Biotechnology Select Industry Index	24/06
Immunome Insider Bought Shares Worth $1,388,072, According to a Recent SEC Filing	21/05
Immunome Completes Purchase of Antibodies From Atreca	20/05
Immunome Promotes Max Rosett to Chief Financial Officer	20/05
Immunome Announces Completion of Purchase of Assets from Atreca	20/05
Immunome, Inc. completed the acquisition of Substantially all Assets of Atreca, Inc..	20/05
Immunome Appoints Max Rosett as CFO	17/05
Immunome Announces Promotion of Max Rosett to Chief Financial Officer	17/05
Immunome, Inc. Announces Promotion of Max Rosett to Chief Financial Officer	17/05
Immunome Reports First Quarter 2024 Financial Results and Provides Business Update	14/05
Immunome, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Certain Common Stock of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2024.	14/05
Certain Warrants of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2024.	14/05
Certain Stock Options of Immunome, Inc. are subject to a Lock-Up Agreement Ending on 14-MAY-2024.	14/05
Immunome to Present at 2024 Bank of America Healthcare Conference	08/05
Immunome Appoints Kinney Horn as Chief Business Officer	02/05
Immunome, Inc. Appoints Kinney Horn as Chief Business Officer	02/05
Immunome, Inc. Announces Executive Changes	30/04

No hay resultados para esta búsqueda